Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dose-Ranging Study of GW642444 (Vilanterol) in Asthma
NCT00347139Phase 2Completed
- Sponsor
- GSK
- Start
- May 2006
- Primary completion
- Jan 2007
- Modality
- Small Molecules
- Countries
- 5
01
Overview
Phase 2, randomised, double-blind trial of vilanterol in asthma (5 arms), sponsored by GSK. Primary endpoint: Mean change from Baseline in trough Forced Expiratory Volume in 1 second at 14 days. Started May 2006; status: completed.
02
Drugs
vilanterol
03
Conditions
asthma
Beyond the preview
Go deeper on NCT00347139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00347139.